SCHEMBL480699

SCHEMBL480699

CCCC(Nc1ccc(N(CC(C)(C)N)S(C)(=O)=O)cc1)=C1C(=O)Nc2cc(C(=O)OCC)ccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.40
MAPT P10636 8/20 0.38
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
GAA P10253 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
USP2 O75604 1/20 0.36
SMN1; SMN2 Q16637 4/20 0.35
CA1 P00915 3/20 0.35
CA2 P00918 3/20 0.35
NPC1 O15118 2/20 0.35
ALDH1A1 P00352 2/20 0.35
RAB9A P51151 2/20 0.35
CA12 O43570 2/20 0.35
CA9 Q16790 2/20 0.35
LMNA P02545 2/20 0.35
MAPK1 P28482 1/20 0.35
POLB P06746 2/20 0.34
SREBF1 P36956 1/20 0.34
NR1H3 Q13133 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2123671 0.94 POLB (0.40) RXFP1MAPTMEN1KMT2AGAA
SCHEMBL2119206 0.94 RXFP1 (0.41) RXFP1MAPTMEN1KMT2AGAA
SCHEMBL480698 0.88 RXFP1 (0.39) RXFP1MAPTMEN1KMT2AGAA
SCHEMBL2567052 0.88 RXFP1 (0.39) RXFP1MAPTMEN1KMT2AGAA
SCHEMBL479375 0.87 POLB (0.41) RXFP1MAPTMEN1KMT2AGAA
SCHEMBL479335 0.84 RXFP1 (0.46) RXFP1MAPTMEN1KMT2AGAA
SCHEMBL2124322 0.83 RXFP1 (0.40) RXFP1MAPTMEN1KMT2AGAA
SCHEMBL2121867 0.82 POLB (0.42) RXFP1MAPTMEN1KMT2AGAA
SCHEMBL479427 0.82 ALDH1A1 (0.40) RXFP1MAPTMEN1KMT2AGAA
SCHEMBL2119204 0.81 RXFP1 (0.40) RXFP1MAPTMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9844572-B2 Promotion of neuronal integration in neural stem cell grafts LIFE & BRAIN GMBH (DE) 2017-12-19 US disclosed
EP-2411034-B1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS LIFE & BRAIN GMBH (DE) 2017-07-26 EP disclosed
US-20120093832-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS LIFE & BRAIN GMBH (DE) 2012-04-19 US disclosed
EP-2411034-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS Life & Brain GmbH (DE) 2012-02-01 EP disclosed
WO-2010108665-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS LIFE & BRAIN GMBH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120093832-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS DCX, NGF, BDNF RXFP1 2731/4885MAPT 960/4885MEN1 2047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.